Corlieve Therapeutics

📍 Paris, France🗓 Founded 2019👥 5 employees💰 Last funded Nov 2020
Biotechnology Research🌐 corlieve.com
Website LinkedIn
Corlieve Therapeutics, a fully owned subsidiary of UniQure, is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Hong Kong SAR
1
Frequently asked questions
Who invested in Corlieve Therapeutics?
Corlieve Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Corlieve Therapeutics last raise funding?
The most recent investment in Corlieve Therapeutics recorded on gritt.io was in November 2020.
When was Corlieve Therapeutics founded?
Corlieve Therapeutics was founded in 2019.
What industry is Corlieve Therapeutics in?
Corlieve Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Corlieve Therapeutics based?
Corlieve Therapeutics is headquartered in Paris, France.